Vicor Technologies' PD2i nonlinear algorithm and software: a promising diagnostic for in-field trauma triage

David H. Fater, CEO of Vicor Technologies, Inc. (OTCBB: VCRT), today announced that Andriy Batchinsky, MD, a researcher with the U.S. Army Institute of Surgical Research (USAISR), identified Vicor's proprietary PD2i® nonlinear algorithm and software as the most promising diagnostic for in-field trauma triage during a presentation before several hundred attendees at the American Heart Association's Resuscitation Science Symposium 2009 on November 14, 2009 in Orlando, Florida. Vicor Technologies is a biotechnology company focused on the commercialization of innovative, non-invasive medical devices and diagnostics using its patented, proprietary PD2i® nonlinear algorithm and software to stratify patients at risk of sudden cardiac death and trauma victims in need of lifesaving intervention.

Dr. Batchinsky's presentation -- "Does Heart-Rate Complexity Analysis Work in the Real World? Changes in the Point Correlation Dimension of Heart Rate During Prehospital Lifesaving Interventions" -- provided a review of trauma triage diagnostics, including Vicor's PD2i® nonlinear algorithm and software, currently being evaluated by the USAISR. The American Heart Association's Resuscitation Science Symposium (ReSS) is an international forum for fundamental, translational, clinical, and population scientists and care providers to discuss recent advances related to treating cardiopulmonary arrest and life-threatening traumatic injury.

According to Dr. Batchinsky, current methods have proven inadequate in improving trauma triage on the battlefield; newer methods employing enhanced mathematical analysis of heart rate complexity (HRC) from EKG data are more promising in pristine, clinical settings, but have not proven reliable in real-world situations with only small amounts of "noisy" or "raw" data, and that the only diagnostic to provide consistently accurate results is Vicor's PD2i® nonlinear algorithm and software, which requires just one to two minutes of EKG data, and is not derailed in delivering actionable results by "noisy" or "raw" data.

"The data presented by Dr. Batchinsky clearly identifies Vicor's PD2i® nonlinear algorithm and software, from amongst other 'vital sign' diagnostics using EKG data to evaluate HRC, as a critical new trauma triage tool with the ability to consistently, accurately identify those requiring lifesaving intervention," stated Edward F. Lundy, MD, PhD. "Importantly, the PD2i® nonlinear algorithm is able to accomplish this lifesaving accuracy in real world situations where time is of the essence and the collection of 'clean' data is never guaranteed. As such, Vicor's PD2i® nonlinear algorithm is a new vital sign with the ability to actually save lives in both combat and civilian settings," Dr. Lundy concluded. Dr. Lundy is Chief of Cardiothoracic Surgery at the Active International Cardiovascular Institute at Good Samaritan Hospital in Suffern, New York and a member of Vicor's Scientific Advisory Board.

"We're extremely pleased and honored to have Dr. Batchinsky share the USAISR's validation of the efficacy of our PD2i® nonlinear algorithm at this well-attended, prestigious symposium," stated Mr. Fater. "Dr. Batchinsky has been actively involved in all of the clinical trials of the PD2i VS™ (Vicor's Vital Sign application of the PD2i® nonlinear algorithm) conducted under our collaborative agreement with the USAISR," stated Mr. Fater. "As such, he has directly witnessed the efficacy of the PD2i® nonlinear algorithm to consistently and accurately determine severity of injury and the probability of survival in critically injured soldiers and civilians utilizing both 'raw' and 'noisy' EKG data, which is consistent with the EKG data that will be collected from trauma victims in actual battlefield and emergency situations," Mr. Fater concluded.

Additional studies by the USAISR of automated trauma triage using the PD2i VS™ are planned.